12-Month Open-Label Extension Study of Intepirdine (RVT-101) in Subjects With Alzheimer's Disease: MINDSET Extension
Clinical trial NCT02586909 · TERMINATED
Trial details
- NCT number
- NCT02586909
- Sponsor
- Axovant Sciences Ltd.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-26
- Primary completion
- 2018-03-12
- Enrollment
- 1099
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.